Time to BBVNA Relief
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorYale University
About this trial
Basivertebral nerve ablation (BVNA) is a minimally invasive procedure approved for vertebrogenic low back pain. While early studies support its efficacy, real-world evidence is still evolving, particularly regarding the trajectory of pain relief and functional improvement over time, and predictors of clinical response. This study aims to evaluate clinical outcomes longitudinally following BVNA and identify baseline predictors of response.
Eligibility criteria
Qualifiers
Diagnosis of chronic axial low back pain with vertebrogenic features
Scheduled for BVN ablation
Able to provide informed consent
Capable of participating in weekly virtual/telephone follow-up for 8 weeks and in- person or remote follow-up at 3 and 6 months through 2 years
Disqualifiers
Prior spinal neuromodulation therapy (e.g., spinal cord stimulation or intrathecal pump) within the past 6 months
Active substance use disorder or uncontrolled psychiatric illness that may interfere with participation
Cognitive impairment limiting ability to complete surveys or provide informed consent
Pregnancy
Trial design
Treatments tested in this trial
- Basivertebral nerve ablation
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov